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‘Breastfeeding and the substance exposed mother and baby’  
Abstract  
Background: Breastfeeding rates are typically low for women with a substance use 
disorder. This is despite the specific benefit of breastfeeding to alleviate the severity 
of neonatal abstinence syndrome and the well-documented generic advantages.  
This study explored the feasibility of in-hospital, tailored breastfeeding support for the 
substance exposed mother and baby. 
 
Methods:  this was a mixed methods feasibility study, in Scotland from April 2014 to 
May 2015. Women with a substance use disorder received either standard Baby 
Friendly Initiative care only or were given additional support which included a 
dedicated breastfeeding support worker; personalised capacity building approach 
and a low stimuli environment for 5 days.  Feasibility outcome measures were 
maternal recruitment, satisfaction and acceptability of support; breastfeeding on 5th 
postnatal day and severity of neonatal abstinence syndrome. 
 
Results:  14 mother/infant dyads participated.  Intervention participants 
demonstrated higher rates of continued breastfeeding and reported a greater degree 
of satisfaction with support and confidence in their breastfeeding ability.  Maternal 
experience of health care practices, attitudes and postnatal environment influenced 
their perceptions of breastfeeding support. Breastfed infants were less likely to 
require pharmacotherapy for neonatal withdrawal and had a shorter hospital stay.  
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Conclusions: the findings highlight the feasibility of tailored breastfeeding support 
for the substance exposed mother and baby and endorse the promotion and support 
of breastfeeding for this group. Future research of a statistically powered randomized 
controlled trial to evaluate clinical efficacy is recommended.    
 
Keywords: breastfeeding, neonatal abstinence syndrome, non-pharmacological 
care, substance use disorder. 
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Introduction  
 
The use and misuse of addictive substances is an ongoing global health and social 
problem and substance dependence in pregnancy is particularly concerning as this 
affects maternal, fetal and neonatal well-being (1). The recommended management 
of substance use in pregnancy is a harm reduction programme inclusive of opioid 
substitution medication.  However, while this strategy stabilises pregnancy viability it 
places the newborn at risk of neonatal abstinence syndrome (2).   Infants affected by 
abstinence syndrome may experience symptoms such as adverse neuro-behaviour, 
feeding difficulties, respiratory distress and seizures. Due to the illicit nature of 
substance use and differing diagnostic practices there is significant variability in the 
recorded prevalence of abstinence syndrome but accumulated data suggests this 
condition is a significant public health challenge globally (2–6/1000 live births) (3). 
This highlights the potential health, social, economic and human costs of the current 
situation and the imperative need for effective management (4, 5).  
Current guidelines recommend the use of supportive care to alleviate the severity of 
neonatal withdrawal. Supportive care includes consolation measures of swaddling, 
non-nutritive sucking and environmental modifications to minimise external stimuli 
(6). Breastfeeding, when not medically contraindicated, should be promoted as the 
transfer of substitution medication in the breast milk and the physical act of 
breastfeeding are thought to provide comfort for the infant (7).  If supportive care is 
insufficient to ease withdrawal symptoms secondary management of 
pharmacotherapy is indicated (8, 9).    However, pharmacotherapy prolongs the 
length of hospital stay for the infant. This increases health care costs and has the 
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potential to interfere with mother/infant bonding due to separation (6). There is also 
ongoing debate regarding the long-term impact of opiate and barbiturate therapy on 
the developing neonatal brain (8, 9).  
Given the disadvantages of pharmacotherapy, supporting breastfeeding in the initial 
postnatal period may optimise the effectiveness of non-pharmacological care.  
Previous research has demonstrated an association between breastfeeding and 
improved outcomes for infants at risk of abstinence syndrome (10). These include a 
reduced need for pharmacotherapy, lower abstinence scores and a shorter duration 
of hospitalization for breastfed infants or those given breast milk containing opiates 
compared to formula feeding (11,12).    Many women who are substance dependent 
during pregnancy feel guilt and responsibility for the baby’s condition and 
breastfeeding, as an act only the mother can perform, enables them to positively 
impact the baby’s health (13). This may contribute to mother/infant attachment, 
which has been noted as problematic in this group (6).  Allied to these specific 
advantages exclusive to substance dependence, breastfeeding also conveys generic 
health, psychological and economic benefits for the mother and child (14).    
Significant challenges exist to achieving improved breastfeeding outcomes for 
substance dependent women, with the reasons for this thought to be multifactorial. 
Current initiation rates are well below national averages and high attrition levels are 
common in the first postnatal week when opioid withdrawal symptoms peak (15).     
Substance dependence is associated with socio-economic deprivation where the 
established norm of formula feeding has led to low maternal self-confidence in 
breastfeeding ability and an expectation of failure (16). This influences initiation rates 
and maternal perseverance when breastfeeding difficulties arise. Additionally, the 
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adverse impact of withdrawal symptoms on the infant’s physical feeding ability, such 
as an uncoordinated sucking pattern and agitation, presents a further challenge (17).  
The safety of breastfeeding in conjunction with substance use continues to be 
questioned in the health care literature despite substantial evidence of the low 
bioavailability of opioids in breastmilk (10, 18). Furthermore, a lack of practitioner 
knowledge, competence or confidence is thought to contribute to both poor 
promotion of breastfeeding in the antenatal period and discouraging and restrictive 
institutional practices postnatally (19, 20). 
Given the advantages and the noted barriers, there is a need to actively promote and 
enable breastfeeding for substance dependent mothers. Yet there is limited research 
on ways in which practitioners can facilitate women to sustain breastfeeding.   This 
paper explores the feasibility of in-hospital, tailored breastfeeding support for the 
substance exposed mother and baby.  
Methods 
The research design was a mixed method pilot study, including a randomized 
controlled trial and maternal questionnaire.  The primary objective was to evaluate 
the feasibility of the intervention, and to assess whether a future adequately powered 
randomized controlled trial was warranted (21).  The research was conducted in a 
tertiary maternity hospital and participant recruitment was undertaken between April 
2014 and May 2015. The study was approved by the North of Scotland Research 
Ethics Committees and National Health Service Grampian Research and 
Development. Maternal written consent was obtained prior to study randomization 
and verbal consent re-assessed daily from intervention participants.  
Intervention  
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The intervention group received integrated support based on practical breastfeeding 
advice, promotion of maternal self-efficacy through encouragement and persuasion, 
and provision of neonatal self-consolation techniques within a low stimuli 
environment.    This included a 1-hour daily scheduled session with a dedicated 
support worker. The support workers were Baby Friendly Initiative trained with 
additional instruction in facilitating breastfeeding in the context of neonatal 
withdrawal. During the daily sessions the support worker collaborated with the 
mother to identify breastfeeding barriers, problem solve and set individualised, 
family-centred goals.    Environmental modifications to minimise external stimuli 
included a designated area with regulated noise levels, temperature control and 
reduced activity.  The infant was nursed in a shielded cot and canopy to limit 
exposure to light and the mother was provided with, and instructed on the use of, 
consolation techniques such as non-nutritive sucking and loose swaddling to assist 
neonatal self-soothing.  This was delivered in addition to the breastfeeding support 
available to all postnatal women and was made available from birth up to, and 
including, the 5th postnatal day. This duration was chosen to coincide with the period 
of neonatal withdrawal expected of in-utero opiate exposure (2).  
The control group received standard postnatal care of the neonate at risk of 
abstinence syndrome. This included first line management of supportive care 
although the mother and baby could be allocated to a multi-occupancy room (not a 
low-stimuli environment). Feeding advice was provided by ward staff and 
underpinned by the UNICEF ten steps to successful breastfeeding (14). Severity of 
neonatal withdrawal was assessed every 4-6 hours using the Finnegan Neonatal 
Scoring System and 3 consecutive scores of 8, or three scores equal to, or greater 
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than, 24 was indicative of severe withdrawal requiring admission to the neonatal unit 
for pharmacotherapy (22).  
Participants and setting  
Participants were recruited from a combined specialist obstetric/substance use clinic. 
Inclusion criteria included opioid substitution medication therapy during pregnancy, 
intention to breastfeed, greater than 36-week gestation and over 16 years of age. 
Exclusion criteria included HIV positive, ongoing illicit psychoactive drug or alcohol 
use and a child removal order in force. Contact was made through the clinic team, 
who acted as gatekeepers and forwarded details to the researcher of eligible women 
expressing an interest in study participation (23).    Women were recruited in the 
antenatal period and visited post birth to assess their continued eligibility and 
reconfirm their wish to participate in the study.   Written consent was then obtained.   
Participants were randomly allocated to the intervention or control group using a 
computer-generated randomization process.  Allocation to group was not concealed 
following the randomization process as intervention participants were located in a 
specifically designated area. As is standard for a feasibility study, recruitment was 
not bound by a predetermined sample size but by the study duration (21). 
Data collection and analysis 
The study outcome explored intervention feasibility defined as maternal participation 
with, and acceptability of, the study and whether it warranted further research by 
demonstrating a trend towards breastfeeding on the 5th postnatal day and impact on 
withdrawal severity. Breastfeeding was defined as feeding at breast; ongoing 
attempts to latch onto breast and expressed breastmilk given for greater than 50% of 
oral intake.  This liberal evaluation of breastfeeding was made to allow for the 
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potential of medical recommendation to maintain neonatal nutrition during this critical 
period but there was ongoing maternal commitment to establish breastfeeding (2). 
Neonatal abstinence severity was evaluated by the need for pharmacotherapy to 
alleviate withdrawal symptoms and length of hospital stay.  
Data collection included recruitment, randomization and retention rates, maternal 
and neonatal demographics and infant feeding on 5th postnatal day, neonatal 
pharmacotherapy and length of hospital stay. Demographic characteristics, numbers 
and responses were entered into Statistical Package for the Social Sciences 
software. A summary of the data as descriptive statistics, percentages, 
epidemiological range, means and standard deviation were obtained. Maternal 
perspective of breastfeeding support was solicited in a questionnaire with five Likert 
scale questions and free text comments. Maternal comments were analysed using 
thematic analysis conducted by two researchers (24). Thematic Analysis uses a 
process of coding to identifying patterns and themes to examine the meaning of the 
data and thus provide a description of the social reality of the phenomenon.   
Results 
 
Participants  
The intervention and control groups had similar maternal and neonatal baseline 
characteristics. All of the participants were white British with the majority prescribed 
methadone as substitution medication.  The intervention group contained more 
multiparous women with greater parity than the control group.  Due to the larger 
percentage of previous children there were also more intervention group women with 
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prior breastfeeding experience, 4 participants having breastfed before compared to 
only 1 in the control group.  (Table 1) 
From the annual clinic case load of 53 women the clinic team referred 19 women 
who met the eligibility criteria in the antenatal period and consented for their details 
to be passed to the research team. Of this number, 1 woman declined participation 
and 4 others became ineligible prior to postnatal randomization. Ineligibility occurred 
due to premature birth, pre-birth child protection order, admission to neonatal 
intensive care unit due to respiratory distress at birth and failure of the referral 
process leading to one woman being missed from study enrolment. There were 14 
mother and infant dyads randomly assigned (74% of those referred). At study 
completion 3 women did not return the maternal questionnaire resulting in a 
completion of 11/14 (78%) (Figure 1).  
Breastfeeding rates and measures of neonatal withdrawal severity 
On the 5th postnatal day 100% (7/7) of the intervention group were still breastfeeding 
compared to 57% (4/7) of control participants (Table 1). Of the intervention group 
28% (2/7) required pharmacotherapy for severe withdrawal compared to 57% (4/7) in 
the control group. The intervention group also had a shorter duration of 
hospitalization (Mean 10.5 days) than the control group (Mean 19.4 days).  
 
Collectively breastfed infants were less likely to require pharmacotherapy (3/11 
breastfeeding vs 3/3 formula feeding).  Breastfeeding infants were discharged from 
the hospital sooner than formula fed infants (10.8 days and 30.0 days, respectively 
(Table 2).  
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Factors influencing maternal satisfaction and acceptability of breastfeeding support   
There were 11 exit questionnaires returned, (intervention n=5, control n=6). Women 
were asked 5 Likert-scale questions (Table 3). The intervention participants felt they 
were encouraged by staff to breastfeed and demonstrated an increased level of 
satisfaction and confidence with breastfeeding. The control group had a greater 
reticence to ask for assistance and felt less supported.   
The questionnaire asked ‘what was good about breastfeeding support and what 
could be improved?’   Thematic analysis generated five key themes relating to 
breastfeeding support and substance exposure. These were the influence of (i) 
breastfeeding skill and knowledge (ii) psychological factors (iii) person-centred 
approach (iv) environmental modifications and (v) postnatal experience on 
breastfeeding.  
Theme 1: Influence of breastfeeding skill and knowledge 
This theme concerned ‘how to’ breastfeed and included information on the normal 
physiology breastfeeding process and specific advice on the impact of substance 
dependence on breastfeeding. 
The physical difficulties of breastfeeding an infant experiencing withdrawal, 
particularly positioning and latching to the breast, was a major concern.  The three 
mothers who discontinued breastfeeding all mentioned difficulties with 
latch/attachment as a determining factor with one mother reporting her baby was ‘too 
agitated’ to latch whilst another mother felt that her baby was ‘too sleepy’. 
Overwhelmingly, the practical aspects of infant feeding drew the most responses 
from both the intervention and control groups: 
“Showing me the rugby ball position which I found much easier” 
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(Intervention) 
 
“Helped me latch on when struggling with different positions” 
(Control) 
 
Access to a support worker resonated as a key advantage among the intervention 
group.  The value of additional support was emphasised and the scheduled visits 
were considered as a ‘safety net’ should they be needed: 
 “I was really pleased with the extra support of a worker coming in and helping 
me as the midwives on duty are very busy and sometimes can’t help.” 
(Intervention) 
 
“Having someone here for me just in case was a great thing.” 
(Intervention) 
Advice and information provision were viewed as an essential component of support 
but mixed experiences were reported: 
“The staff are amazing, patient and kept me well informed.” 
(Intervention) 
 However, respondents felt that whilst generic breastfeeding information was 
important this lacked sufficient relevance for their situation: 
“I have had plenty of advice and encouragement about breast feeding from 
hospital staff but not very much advice or information about babies with 
symptoms of neonatal abstinence syndrome.” 
(Control)  
 
Theme 2: Influence of psychological factors on breastfeeding support  
This included the need for emotional support to sustain breastfeeding and the 
importance of positive reassurance and encouragement.  
“The five days was very positive and having someone here for me 
encouraging me daily was brilliant.” 
(Intervention) 
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Additionally, practitioner attitudes and non-verbal behaviour influenced the mother’s 
emotional well-being. Conveying a relaxed, positive demeanour returned a similar 
attitude by the participant.  
“when (support worker) came to help us she was great, she had a wide 
knowledge and was very laid back, made things feel so simple and natural” 
(Intervention) 
 
Theme 3: Influence of person-centred approach on breastfeeding support  
The person-centred approach focussed on providing individualised and socio-
culturally relevant support. Having a dedicated support worker and time allocated 
exclusively for the individualised needs of mother and baby was viewed as 
beneficial:  
“Knowing someone was coming to help me every morning was ace.” 
(Intervention) 
This included identifying the level and type of support required and tailoring the daily 
sessions accordingly: 
“To be honest my baby latched on with no problems at all, so didn’t need any 
help at all but I was asked if I wanted any help.” 
(Intervention) 
 
Theme 4: Influence of environmental modifications  
Environmental conditions were integral for effective neonatal supportive care and the 
inability to reduce external stimuli was cited as a negative feature of the postnatal 
experience: 
“I was on a ward with 4 other lady’s & 4 other babies. It was a bit impossible 
to create a quiet environment especially at visiting time. There is no way I 
could have dimmed lights for my baby.” 
(Control) 
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Whilst another mother was not informed about consolation techniques during her 
hospital stay: 
“I only know of swaddling through talking with my community midwife before 
being admitted to hospital”. 
(Control) 
 
Theme 5: Influence of postnatal experience on breastfeeding support  
Postnatal experience relates to health care practices and attitudes which may not be 
directly connected to support but can influence maternal receptiveness to support. 
These focussed on issues of privacy, confidentiality and respectful practice. With the 
lack of confidentiality, particularly when discussing substance use, a major failing.  
 “I found it wasn’t very private and some of the staff were quite “easy” to 
discuss confidential matters openly without a thought for who might be 
listening on the other side of the curtains.” 
(Control) 
One mother felt confident establishing breastfeeding while in single accommodation, 
however, following transfer to the neonatal unit, the lack of privacy negatively 
affected her breastfeeding experience: 
“I didn’t feel comfortable breastfeeding in front of other visitors, even with the 
screen it always felt too busy which made me wait until late feeds when it was 
quiet to feed.” 
(Intervention) 
Discussion 
 
The study explored the feasibility of tailored breastfeeding support for the substance 
exposed mother and baby. The ability to recruit from a group considered difficult to 
engage was used as a measure of feasibility and although the initial recruitment was 
modest, retention of participants during the study was encouraging.  There was a 
demonstrated trend for continued breastfeeding on the 5th postnatal day and 
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intervention participants reported increased breastfeeding confidence and 
satisfaction. Breastfed infants were less likely to require pharmacotherapy for 
neonatal withdrawal and had a shorter hospital stay. Collectively, the findings 
indicate the potential of the support model to improve both maternal and neonatal 
outcomes. 
Study recruitment was anticipated as a possible challenge. Historically breastfeeding 
was contra-indicated for those with a substance addiction and despite the reversal of 
this restriction, breastfeeding rates remain below national averages (3). Some 
medical facilities continue to report discouraging attitudes to breastfeeding inclusion 
for opiate maintained women and a national survey noted practitioners consistently 
displaying negative views towards the promotion and support of breastfeeding for 
infants at risk of abstinence syndrome (19, 20). These factors may have played a 
part in the small number of women forwarded as eligible for participation in our 
study. Encouragingly, a recent large-scale hospital evaluation reported that the 
percentage of substance exposed infants receiving breast milk increased from 20% 
in 2004–2005 to 35% by 2012–2013 (25). These findings imply that there is a 
gradual reversal in attitudes with women and health care professionals now actively 
responding to, and receptive of, breastfeeding promotion in conjunction with 
substance addiction.  
The intervention participants had higher breastfeeding rates and expressed a greater 
confidence in their breastfeeding ability than the control group. However, there was a 
disparity in prior breastfeeding experience between the two groups and as previous 
positive or negative breastfeeding experience can be a modifying factor in a 
subsequent pregnancy this must be considered in the evaluation (14). In support, the 
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study findings do correlate with existing research conducted with women of various 
demographics, which indicates that all forms of extra support may increase the 
duration of either exclusive or continued breastfeeding (26).  Contrastingly, previous 
studies have reported variability in the acceptability and perceived efficacy of the 
same breastfeeding support initiative when delivered to socio-demographically 
similar groups but in different settings (27). These contradictions highlight the 
influence of both context and personal choice on breastfeeding decisions.  This 
resonates with the study finding that health care practices and practitioner actions 
and attitudes were an influencing factor on maternal postnatal experience. Negative 
experiences, such as a perceived lack of privacy and compromised confidentiality, 
can be devastating for this group in terms of loss of trust and fear of being 
stigmatised by others.  Trust and confidence in the health care system as a whole 
can be jeopardised, impeding the establishment of a rapport between the mother 
and practitioner and indirectly, maternal receptiveness to breastfeeding advice (28). 
Given the current paucity of research regarding breastfeeding and substance 
dependence, and the inconsistency of how support is perceived by individuals and 
homogenous groups, further exploration of the beliefs and attitudes of opioid 
dependent women is warranted. 
Our finding that breastfed infants displayed a milder course of neonatal withdrawal is 
consistent with prior studies (10).  For example, a prospective case control study and 
several retrospective chart reviews have consistently shown that breastfeeding 
alleviates withdrawal severity (11, 12, 18). None of these studies however, used a 
randomized controlled design highlighting the need for robust evaluation of infant 
feeding and substance dependence.   
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This study evaluated an integrated model offering a novel approach to the 
management of neonatal withdrawal by incorporating breastfeeding, a supportive 
environment and fostered maternal capacity building.  A previously reported study 
promoted a low stimulation environment and encouraged parents as partners in 
care-giving as a means of alleviating withdrawal severity, but this did not include 
specific breastfeeding support (29). Similarly, other research has concentrated on 
increasing family involvement in the delivery of non-pharmaceutical therapy and a 
‘care bundle’ approach to management (30, 31). These studies assessed 
intervention efficacy in terms of hospital duration and /or health care costs, and all 
demonstrated an improvement. It could be argued, therefore, that a model including 
family focused care which collaboratively fosters a therapeutic mother/child 
relationship and places breastfeeding at its centre should also improve clinical and 
economic outcomes.    
Strengths and Limitations 
A strength of the study is the prospective nature of the evaluation and the unique use 
of a randomized controlled trial design in this context.  With the paucity of similar 
controlled trials, a benefit of the current research is the generation of data to inform 
the parameters of a future statistically powered study.  
A number of limitations should be acknowledged when interpreting the study 
findings.  The study used a single site only, recruiting from one substance 
dependence clinic, and there was homogeneity of the population. Whilst the sample 
group was not dissimilar to other studies conducted amongst substance dependent 
mothers in Scotland, it is accepted that the research may not be representative of 
other geographic settings or where health service provision differs (32).  
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Conclusion 
This study highlights the feasibility and potential benefits of tailored breastfeeding 
support for the substance exposed mother and baby. However, the small sample 
size limits our ability to comment on clinical efficacy.  Future research should include 
a statistically powered, blinded, randomized trial to evaluate clinical efficacy.
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Table 1  
Mixed methods feasibility study of breastfeeding support in substance dependence: 
Maternal and neonatal participant characteristics, Scotland, 2015. 
 
  Intervention Control Total 
 n=7 n=7 n=14 
Characteristics  n (%) n (%) n (%) 
MATERNAL 
Age                 
(years)            
 
Parity               
 
 
Substitution     
Medication      
 
Prior breast     
Feeding           
 
Birth             
Outcome       
 
NEONATAL 
Gestation 
(weeks+days) 
 
Birth weight (kg) 
 
Feeding @ Day 5                       
 
 
Pharmacotherapy    
                                    
 
Length of hospital stay         
Mean±SD 
 
20-35 
>35 
 
nulliparous 
multiparous  
 
methadone 
buprenorphine 
 
yes 
no 
 
spontaneous 
assisted* 
 
 
 
 
 
 
 
breastfeeding 
formula 
 
yes 
no 
 
 
  
 
 
5(71) 
2(29) 
 
1(14) 
6(84) 
 
7(100) 
0 
 
4(57) 
3(43) 
 
4(57) 
3(43) 
 
 
 
38+3-41+4 
 
3.0 – 3.9 
 
7(100) 
0 
 
2(29) 
5(71) 
 
5-24 
10.5±7.0 
 
 
4(57) 
3(43) 
 
3(43) 
4(57) 
 
6(84) 
1(14) 
 
1(14) 
6(84) 
 
4(57) 
3(43) 
 
 
 
36+6-41+0 
 
2.8 – 3.8 
 
4(57) 
3(43) 
 
4(57) 
3(43)  
 
7-43 
19.4±13.0 
 
 
 
9(64) 
5(36) 
 
4(28) 
10(71) 
 
13(93) 
1(7) 
 
5(36) 
9(64) 
 
8(57) 
6(43)  
 
 
 
36+6-41+4 
 
2.8-3.9 
 
11(79) 
3(21) 
 
6(43) 
8(43) 
 
5-43 
14.9±11.1 
 
 
*Assisted birth includes instrumental and operative delivery 
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Table 2  
Mixed methods feasibility study of breastfeeding support in substance dependence: 
pharmacotherapy and length of hospital stay for infants at risk of Neonatal 
Abstinence Syndrome by infant feeding method, Scotland 2015. 
 
 
  Breastfeeding Formula 
  N=11 N=3 
  n (%) n (%) 
Neonatal Abstinence Severity  Mean±SD Mean±SD 
Pharmacotherapy 
 
 
Length of hospital stay  
range(days) 
Yes 
No 
 
 
 
 
 
3(21.5) 
8(57) 
 
5-22 
10.8± 6.7 
3(21.5) 
0 
 
20-43 
30.0± 11.8 
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Table 3  
Mixed methods feasibility study of breastfeeding support in substance dependence: 
maternal questionnaire, Scotland 2015. 
 
  
 Intervention Control Total 
 n=5 n=6 N=11 
Likert question** Mean±SD Mean±SD Mean±SD 
Staff encouraged me to breastfeed  
 
I asked for help when I needed 
support  
 
I always received help when I asked 
for it 
 
I am satisfied with the support I was 
given in hospital  
 
I feel confident breastfeeding 
9.0± 2.2 
 
8.8± 1.1 
 
 
9.2± 1.3 
 
 
9.6± 0.9 
 
 
9.0± 1.7 
 
 
6.4± 2.9 
 
5.4± 3.7 
 
 
6.4± 2.3 
 
 
6.8± 2.2 
 
 
4.3± 21 
 
7.7± 2.8 
 
7.1± 3.1 
 
 
7.8± 2.3 
 
 
8.2± 2.2 
 
 
6.9± 3.1 
 
 
** Likert score 1(completely disagree) to 10 (completely agree) 
 
 
